Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma, Neuroendocrine × Disulfides × Clear all

Sponsor

Conditions

Ovarian Neoplasms 14 Fallopian Tube Neoplasms 14 Glioblastoma 7 Lung Neoplasms 6 Carcinoma, Renal Cell 6 Carcinoma, Non-Small-Cell Lung 6 Brenner Tumor 6 Colorectal Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Melanoma 4 Gliosarcoma 4 Breast Neoplasms 4 Brain Neoplasms 4 Uterine Cervical Neoplasms 3 Triple Negative Breast Neoplasms 3 Recurrent Squamous Cell Lung Carcinoma 3 Oligodendroglioma 3 Spinal Cord Neoplasms 2 Prostatic Neoplasms 2 Medulloblastoma 2 Glioma 2 Colonic Neoplasms 2 Carcinoma 2 Astrocytoma 2 Adenocarcinoma of Lung 2 Vipoma 1 Uveal Melanoma 1 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1

Interventions

Everolimus 5 Bevacizumab 2 veliparib 1 pralsetinib 1 pertuzumab 1 pasireotide 1 carfilzomib 1 cabozantinib 1 berzosertib 1 Topotecan 1 Sunitinib 1 Radiotherapy 1 Radiosurgery 1 Podophyllotoxin 1 Platinum 1 Octreotide 1 Nivolumab 1 Ipilimumab 1 Etoposide 1 Cisplatin 1 CTLA-4 Antigen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡